Vaccine
Human papillomavirus vaccine
Brand names: Gardasil 9, Cervarix
Adult dose
Dose: Per UK Green Book — 1 dose for routine 11–14 yrs schedule (since 2023); 2-dose for some catch-up; 3-dose for immunocompromised
Route: IM
Frequency: per schedule
Clinical pearls
- Cervical, anogenital and oropharyngeal cancer prevention; UK programme covers boys and girls aged 12–13 (year 8)
Contraindications
- Severe hypersensitivity to previous dose
Side effects
- Local reaction
- Headache
- Pyrexia
- Myalgia
- Syncope (often vasovagal)
Reference: BNF; UK Green Book; JCVI; https://bnf.nice.org.uk/drugs/human-papillomavirus-vaccine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023